In the BioHarmony Drug Report Database

"Preview" Icon

Risedronate

Actonel, Atelvia (risedronic acid) is a small molecule pharmaceutical. Risedronic acid was first approved as Actonel on 1998-03-27. The pharmaceutical is active against farnesyl pyrophosphate synthase. Risedronate sodium’s patents are valid until 2028-01-09 (FDA).

 

Trade Name

 

Actonel, Atelvia
 

Common Name

 

risedronic acid
 

ChEMBL ID

 

CHEMBL923
 

Indication

 

 

Drug Class

 

Calcium metabolism regulators

Image (chem structure or protein)

Risedronate structure rendering